Successful seed financing for Virtonomy

The start-up from Munich wants to speed up approval processes in medicine. A state investor is also involved.

Virtonomy receives seven-figure seed funding. The lead investor is Dieter von Holtzbrinck Ventures. The VC company of the Free State of Bavaria, Bayern Kapital, as well as Initiative for Industrial Innovators and Plug and Play are also involved.

Virtonomy was founded in 2019 and is working on making approval processes in medicine faster, cheaper and safer. Products should no longer only be tested on humans and animals, but virtually. The company is building virtual, customizable anatomies of human bodies for this purpose. Manufacturers of medical products, such as implants, can use Virtonomy to test their technologies on these virtual patients at all stages of development.

The investment will be used to further develop the technology, build up the database and recruit new employees. "Right from the start, we wanted to develop a solution that not only has economic benefits, but also social benefits," explains Simon Sonntag, CEO of Virtonomy. "The development of new medical technology products is still particularly time-consuming and cost-intensive. That's why young companies like us that want to make a difference in this sector are dependent on strong capital support during the development and growth phase."

Investors also see potential. "In the digitalization of the healthcare sector, there is still enormous potential for the development of innovative solutions and the establishment of market leaders. Virtonomy scores on several counts with its innovative idea: a promising, scalable product with the potential to make the development of medical products more efficient, faster and safer," says Georg Ried, Managing Director of Bayern Kapital.